Progenity (PROG) Receives $44M in Warrant Proceeds, Strengthens its Liquidity Position
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
Progenity Strengthens its Liquidity Position
November 23, 2021 6:30 AM ESTCompany received more than $44 million in warrant exercises since August 2021.
Current liquidity position provides runway to achieve critical research and development milestones through 2022.
SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today provided an update on its strengthened liquidity position.
Over the last several months, we made great strides in optimizing our capital structure and bolstering our liquidity position, said Eric dEsparbes, Chief Financial Officer... More
